Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Oudshoorn-van Marsbergen, Laura"'
Autor:
Ngai, Lok Lam, Hanekamp, Diana, Janssen, Fleur, Carbaat-Ham, Jannemieke, Hofland, Maaike A M, Fayed, Mona M H E, Kelder, Angèle, Oudshoorn-van Marsbergen, Laura, Scholten, Willemijn J, Snel, Alexander N, Bachas, Costa, Tettero, Jesse M, Breems, Dimitri A, Fischer, Thomas, Gjertsen, Bjorn T, Griskevicius, Laimonas, Juliusson, Gunnar, van de Loosdrecht, Arjan A, Maertens, Johan A, Manz, Markus G, Pabst, Thomas, Passweg, Jakob R, Porkka, Kimmo, Valk, Peter J M, Gradowska, Patrycja, Löwenberg, Bob, de Leeuw, David C, Janssen, Jeroen J W M, Ossenkoppele, Gert J, Cloos, Jacqueline
Publikováno v:
Blood, 141(21), 2657-2661. American Society of Hematology
Ngai, L L, Hanekamp, D, Janssen, F, Carbaat-Ham, J, Hofland, M A M A, Fayed, M M H E, Kelder, A, Oudshoorn-van Marsbergen, L, Scholten, W J, Snel, A N, Bachas, C, Tettero, J M, Breems, D A, Fischer, T, Gjertsen, B T, Griškevičius, L, Juliusson, G, van de Loosdrecht, A A, Maertens, J A, Manz, M G, Pabst, T, Passweg, J R, Porkka, K, Valk, P J M, Gradowska, P, Löwenberg, B, de Leeuw, D C, Janssen, J J W M, Ossenkoppele, G J & Cloos, J 2023, ' Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial ', Blood, vol. 141, no. 21, pp. 2657-2661 . https://doi.org/10.1182/blood.2022019160, https://doi.org/10.1182/blood.2022019160
Blood, 141, 21, pp. 2657-2661
Blood, 141, 2657-2661
Blood, Washington : Elsevier B.V., 2023, Early Access, p. [1-13]
Ngai, L L, Hanekamp, D, Janssen, F, Carbaat-Ham, J, Hofland, M A M A, Fayed, M M H E, Kelder, A, Oudshoorn-van Marsbergen, L, Scholten, W J, Snel, A N, Bachas, C, Tettero, J M, Breems, D A, Fischer, T, Gjertsen, B T, Griškevičius, L, Juliusson, G, van de Loosdrecht, A A, Maertens, J A, Manz, M G, Pabst, T, Passweg, J R, Porkka, K, Valk, P J M, Gradowska, P, Löwenberg, B, de Leeuw, D C, Janssen, J J W M, Ossenkoppele, G J & Cloos, J 2023, ' Prospective validation of the prognostic relevance of CD34+CD38– AML stem cell frequency in the HOVON-SAKK132 trial ', Blood, vol. 141, no. 21, pp. 2657-2661 . https://doi.org/10.1182/blood.2022019160, https://doi.org/10.1182/blood.2022019160
Blood, 141, 21, pp. 2657-2661
Blood, 141, 2657-2661
Blood, Washington : Elsevier B.V., 2023, Early Access, p. [1-13]
Item does not contain fulltext
Autor:
Ngai, Lok Lam *, Hanekamp, Diana *, Janssen, Fleur *, Carbaat-Ham, Jannemieke *, Hofland, Maaike A.M. *, Fayed, Mona M.H.E *, Kelder, Angèle *, Oudshoorn-van Marsbergen, Laura *, Scholten, Willemijn J. *, Snel, Alexander N. *, Bachas, Costa *, Tettero, Jesse M. *, Breems, Dimitri A., Fischer, Thomas, Gjertsen, Bjørn Tore *, Griškevičius, Laimonas *, Juliusson, Gunnar, Maertens, Johan A. *, Manz, Markus G, Pabst, Thomas, Passweg, Jakob R., Porkka, Kimmo *, Gradowska, Patrycja *, Lowenberg, Bob, de Leeuw, David C. *, Janssen, Jeroen J.W.M. *, Ossenkoppele, Gert J., Cloos, Jacqueline *
Publikováno v:
In Blood 15 November 2022 140 Supplement 1:9125-9127